Benjamin D. Rogers

Benjamin D. Rogers

Auto-generated profile, based on publicly available information

Benjamin D. Rogers

Division of Gastroenterology, Washington University School of Medicine, St. Louis, MO, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
PDF file
BRBenjamin D. Rogers
Benjamin D. Rogers
ARArvind Rengarajan
Arvind Rengarajan
AMAurelio Mauro
Aurelio Mauro
MGMatteo Ghisa
Matteo Ghisa
Nicola de BortoliNicola de Bortoli
Nicola de Bortoli
CGC. Prakash Gyawali
C. Prakash Gyawali

19 September 2024 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
CGC. Prakash Gyawali
C. Prakash Gyawali
LMLorenzo Marchetti
Lorenzo Marchetti
BRBenjamin D. Rogers
Benjamin D. Rogers
WCWalter W. Chan
Walter W. Chan
MWMing-Wun Wong
Ming-Wun Wong
JPJohn Pandolfino
John Pandolfino
INTRODUCTION: We explored if a score derived from parameters from esophageal testing could increase confidence in diagnosing conclusive gastroesophageal reflux disease and in predicting outcome. METHODS: A prediction score was developed using metrics based on Lyon Consensus 2.0 thresholds extracted from endoscopy and pH-impedance monitoring. The Lyon score was the sum of weighted scores derived from a logistic regression model. The outcome was response to antireflux therapy, defined as 50% reduction in global symptoms on validated questionnaires. An existing database of endoscopy-negative patients with typical reflux symptoms undergoing esophageal testing from 2 centers (Europe and the United States) constituted the developmental cohort, while 2 separate cohorts (Europe and Asia) served as validation cohorts. Receiver operating characteristics analysis determined performance of the Lyon score in predicting treatment response. RESULTS: In 281 developmental cohort patients (median age 53 years, 57.7% female), the Lyon score demonstrated an area under the curve (AUC) of 0.819 in predicting 50% symptom improvement ( P < 0.001) on receiver operating characteristics, with an optimal threshold of 6.25 (sensitivity 81.2%, specificity 73.4%). Of the individual components, only acid exposure time (AUC 0.799, P < 0.001), mean nocturnal baseline impedance (AUC 0.785, P < 0.001), and reflux episodes (AUC 0.764, P < 0.001) approached the Lyon score performance. The Lyon score segregated treatment response in both the European (AUC 0.908, P < 0.001) and Asian validation cohorts (AUC 0.637, P < 0.001) and outperformed the DeMeester score in sensitivity for predicting outcome in the developmental and Asian validation cohorts. DISCUSSION: The novel Lyon score segregates reflux phenotypes and identifies likelihood of symptom response from antireflux therapy.

22 September 2020 in Digestive Diseases
Verified
Journal Article
Closed access
PDF file
BRBenjamin D. Rogers
Benjamin D. Rogers
CSCorey Shy
Corey Shy
RRRajeev Rampgopal
Rajeev Rampgopal
THTricia Hengehold
Tricia Hengehold
AAAymen Almuhaidb
Aymen Almuhaidb
GSGregory S. Sayuk
Gregory S. Sayuk
Introduction: Text message-based interventions reduce colonoscopy no-show rates and improve bowel preparation scores. In this non-randomized study, we assessed whether an interactive text messaging system could improve colonoscopy outcomes. Methods: Colonoscopy pre-procedural instructions were programmed into a dedicated software platform created for this study. In the intervention arm, text messages were sent to veterans during a 4-week study period. Validated pre-procedural satisfaction questionnaires were completed by patients during standard protocol and intervention periods. Demographics and colonoscopy outcomes data were compared between the standard protocol and intervention arms, including procedure completion rate on scheduled date, Boston bowel preparation score (BPPS), adenoma detection rate, and satisfaction. Results: Of 241 patients, 128 were in the standard protocol arm and 113 in the intervention arm. Higher proportions of patients receiving text messages underwent colonoscopy on their scheduled date (69.9%) compared to the ones in the standard protocol (50.8%, p = 0.015). Patients with ≥3 interactions with the system had 80.6% likelihood of completing colonoscopy on the scheduled date compared to 56.9% with <3 interactions and 50.8% with standard protocol (p < 0.001). Frequency of interaction with the system was similar between older (>65 years) and younger patients (p = 1.0). Among older patients, colonoscopy was completed successfully in 84.2% when alert-based human interactions occurred compared to 65.6% in those without and 47.9% with standard protocol (p = 0.018). More than 90% indicated they would recommend the system to patients undergoing future colonoscopy. Conclusion: An interactive text messaging system improves successful colonoscopy rates in a VA setting, with greatest impact in older patients.

1 September 2020 in Gastroenterology Clinics of North America
Verified
Journal Article
Closed access
BRBenjamin D. Rogers
Benjamin D. Rogers
CGC. Prakash Gyawali
C. Prakash Gyawali

25 November 2020 in Diseases of the Esophagus
Verified
Journal Article
Closed access
PDF file
THTricia Hengehold
Tricia Hengehold
BRBenjamin D Rogers
Benjamin D Rogers
FQFarhan Quader
Farhan Quader
CGC Prakash Gyawali
C Prakash Gyawali
Esophageal strictures commonly cause dysphagia and require treatment with endoscopic dilation using balloons or bougies. We aimed to determine whether biopsy forceps disruption of strictures at time of dilation increases time to repeat intervention or duration of intervention-free follow-up. We performed a retrospective analysis of 289 adults (age 61.0 ± 0.8 years, 66.4% female) who underwent dilation of an esophageal stricture at our tertiary care center between 2014 and 2016. Exclusions consisted of endoscopic intervention within the preceding 6 months, prior foregut neoplasia, achalasia, radiofrequency ablation, endoscopic mucosal resection, endoscopic submucosal dissection, or foregut surgery. Demographics, clinical presentation, dilation technique, and follow-up were abstracted from electronic medical records. We compared time to repeat dilation and duration of intervention-free follow-up between treatment subgroups. Balloon dilation was performed more often than bougie dilation (76.8 vs. 17.6%); biopsy forceps disruption was performed in 23.2%. Over a median follow-up of 52.9 months, 135 patients (46.7%) underwent repeat dilation. Age, body mass index, gender, and use of antisecretory medications did not influence need for repeat dilation (P = ns for each). Bougie dilation with biopsy forceps disruption prolonged time to repeat dilation in all patients (P ≤ 0.02), particularly in those with gastroesophageal reflux disease (P ≤ 0.03), compared with bougie dilation alone and balloon dilation with or without disruption. On Kaplan–Meier analysis, bougie dilation with biopsy forceps resulted in longer intervention-free follow-up compared with dilation alone (P = 0.03). We conclude that stricture disruption with biopsy forceps increases time to repeat intervention with bougie but not balloon dilation.

25 June 2021 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Open access
PDF file
BRBenjamin D. Rogers
Benjamin D. Rogers
CGC. Prakash Gyawali
C. Prakash Gyawali
This article is linked to Frazzoni et al papers. To view these articles, visit https://doi.org/10.1111/apt.16371 and https://doi.org/10.1111/apt.16400